This study is designed to assess the efficacy, safety and tolerability of a topical formulation of terbinafine solution applied daily in patients with toenail fungus. This trial will study patients with mild to moderate toenail fungus disease of the big toenail and their responses to two treatment durations, 24 or 48 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
518
Active terbinafine hydrochloride (HCl) 10 % Nail Solution for Onychomycosis (NSO) once daily for 48 weeks
vehicle (placebo) applied once daily for 48 weeks
Active terbinafine hydrochloride (HCl) 10 % Nail Solution for Onychomycosis (NSO) once daily for 24 weeks
Dr. Boni Elewski
Birmingham, Alabama, United States
Dr. Stacy Smith
Efficacy Assessed by Complete Cure Rate at the End of Study (Week 52) After Treating for 24 or 48 Weeks.
Complete cure is defined as negative KOH microscopy and negative culture for dermatophytes. and no residual involvement of the target toenail. The complete cure was a composite binary variable defined as "Yes" if: * Mycological cure (negative KOH and negative culture for dermatophytes) and * No residual involvement of the target toenail "No" if otherwise
Time frame: 52 weeks
Efficacy Assessed by Mycological Cure (Negative Culture and Negative KOH Microscopy) at the End of Study After Treating Patients for 24 or 48 Weeks.
Mycological cure is defined as negative KOH microscopy and negative culture for dermatophytes. Mycological cure was a composite binary variable defined as "Yes"if : * Negative microscopy and * Negative culture for dermatophytes "No" if otherwise.
Time frame: 52 weeks
Efficacy Assessed by Clinical Efficacy at the End of Study After Treating Patients for 24 or 48 Weeks.
Clinical effectiveness is defined as negative KOH microscopy and negative culture for dermatophytes and \<= 10% residual involvement of the target toenail. Clinical effectiveness was a composite binary variable defined as "Yes" if * Mycological cure (negative KOH and negative culture for dermatophytes) and * = 10% residual involvement of the target toenail "No" if otherwise
Time frame: 52 weeks
Number of Participants Assessed With Adverse Events and Serious Adverse Events
An adverse event (AE) is any adverse change in health or side effect that occurs while the participant is receiving the treatment or within a previously specified period of time after the treatment has been completed. A Serious Adverse Event (SAE) is any untoward medical occurrence that results in death, is life-threatening requires, inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect, or requires intervention to prevent permanent impairment or damage.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
vehicle (placebo) applied once daily for 24 weeks
San Diego, California, United States
Dr. James Swinehart
Denver, Colorado, United States
Dr. David G. Armstrong
North Chicago, Illinois, United States
Dr. Kevin Terry
Lutherville, Maryland, United States
Dr. Anthony Puopolo
Milford, Massachusetts, United States
Dr. John Fenyk
Chaska, Minnesota, United States
Dr. Joel Schlessinger
Omaha, Nebraska, United States
Dr. AnneMarie Uliasz
New York, New York, United States
Dr. Willard Niemi
Raleigh, North Carolina, United States
...and 12 more locations
Time frame: 52 weeks